Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 5/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.73 |
| ▸ | MAPT | P10636 | 6/20 | 0.73 |
| ▸ | RECQL | P46063 | 6/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.73 |
| ▸ | APEX1 | P27695 | 5/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.73 |
| ▸ | MEN1 | O00255 | 5/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.73 |
| ▸ | USP2 | O75604 | 4/20 | 0.73 |
| ▸ | BLM | P54132 | 4/20 | 0.73 |
| ▸ | HPGD | P15428 | 4/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.73 |
| ▸ | GALK1 | P51570 | 3/20 | 0.73 |
| ▸ | THRB | P10828 | 2/20 | 0.73 |
| ▸ | CASP1 | P29466 | 2/20 | 0.73 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.68 |
| ▸ | CDK2 | P24941 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29370989 | 0.95 | BCL2 (0.68) | BCL2KDM4EMAPTRECQLTDP1 | |
| SCHEMBL717489 | 0.95 | BCL2 (0.68) | BCL2KDM4EMAPTRECQLTDP1 | |
| SCHEMBL12792863 | 0.85 | BCL2 (0.94) | BCL2KDM4EMAPTRECQLTDP1 | |
| SCHEMBL13300891 | 0.85 | BCL2 (0.94) | BCL2KDM4EMAPTRECQLTDP1 | |
| SCHEMBL14535256 | 0.85 | BCL2 (0.94) | BCL2KDM4EMAPTRECQLTDP1 | |
| Theaflavin Monogallates SCHEMBL13300888 | 0.85 | BCL2 (1.00) | BCL2KDM4EMAPTRECQLTDP1 | |
| Theaflavin Monogallates SCHEMBL12792869 | 0.85 | BCL2 (1.00) | BCL2KDM4EMAPTRECQLTDP1 | |
| Theaflavin Monogallates SCHEMBL12240727 | 0.85 | BCL2 (1.00) | BCL2KDM4EMAPTRECQLTDP1 | |
| Theaflavin Monogallates SCHEMBL12672616 | 0.85 | BCL2 (1.00) | BCL2KDM4EMAPTRECQLTDP1 | |
| Theaflavin Monogallates SCHEMBL12658745 | 0.85 | BCL2 (1.00) | BCL2KDM4EMAPTRECQLTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4423120-A1 | STABILIZED HEMEPROTEIN COMPOSITIONS AND METHODS OF USE THEREOF | Motif Foodworks, Inc. (US) | 2024-09-04 | — | — | EP | claimed |
| CN-117120043-A | Standardized bioflavonoid compositions for regulating host defense mechanism homeostasis | 尤尼根公司 | 2023-11-24 | — | — | CN | claimed |
| EP-4188408-A1 | A STANDARDIZED BIOFLAVONOID COMPOSITION FOR REGULATION OF HOMEOSTASIS OF HOST DEFENSE MECHANISM | Unigen, Inc. (US) | 2023-06-07 | — | — | EP | claimed |
| WO-2023076307-A1 | STABILIZED HEMEPROTEIN COMPOSITIONS AND METHODS OF USE THEREOF | MOTIF FOODWORKS, INC. (US) | 2023-05-04 | — | — | WO | claimed |
| US-20220031654-A1 | Standardized Bioflavonoid Composition for Regulation of Homeostasis of Host Defense Mechanism | UNIGEN, INC. (US) | 2022-02-03 | — | — | US | claimed |
| WO-2022026740-A1 | A STANDARDIZED BIOFLAVONOID COMPOSITION FOR REGULATION OF HOMEOSTASIS OF HOST DEFENSE MECHANISM | UNIGEN, INC. (US) | 2022-02-03 | — | — | WO | claimed |
| WO-2018183353-A1 | SMALL MOLECULE COMPOUNDS TO SUPPORT HEALTHY HUMAN AGING | CARDAX PHARMA, INC. (US) | 2018-10-04 | — | — | WO | claimed |
| EP-2661266-A2 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | Elcelyx Therapeutics, Inc. (US) | 2013-11-13 | — | — | EP | claimed |
| WO-2012094636-A2 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | ELCELYX THERAPEUTICS, INC. (US) | 2012-07-12 | — | — | WO | claimed |
| US-12595220-B2 | Cocrystals of pterostilbene and compositions comprising them | CENTER FOR INTELLIGENT RESEARCH IN CRYSTAL ENGINEERING, S.L. (ES) | 2026-04-07 | — | — | US | disclosed |
| EP-4077258-B1 | COCRYSTALS OF PTEROSTILBENE AND COMPOSITIONS COMPRISING THEM | CENTER FOR INTELLIGENT RES IN CRYSTAL ENGINEERING S L (ES) | 2026-03-25 | — | — | EP | disclosed |
| US-20250183494-A1 | Standardized Bioflavonoid Composition for Regulation of Homeostasis of Host Defense Mechanism | UNIGEN, INC. (US) | 2025-06-05 | — | — | US | disclosed |
| WO-2025070135-A1 | HEXAVALENT-CHROMIUM-REDUCING PHOTOCATALYST COMPOSITION AND METHOD FOR REDUCING HEXAVALENT CHROMIUM | ユシロ化学工業株式会社 | 2025-04-03 | — | — | WO | disclosed |
| EP-4423120-A1 | STABILIZED HEMEPROTEIN COMPOSITIONS AND METHODS OF USE THEREOF | Motif Foodworks, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| WO-2004055048-A2 | CHIMERIC ALPHA Q-GUSTDUCIN G-PROTEINS | GIVAUDAN SA (CH) | 2004-07-01 | — | — | WO | disclosed |
| CN-1413117-A | Drugs, drinks or foods | TAKARA SHUZO CO (JP) | 2003-04-23 | — | — | CN | disclosed |
| EP-1232756-A1 | DRUGS, DRINKS OR FOODS | Takara Shuzo Co, Ltd. (JP) | 2002-08-21 | — | — | EP | disclosed |
| US-5807564-A | MIXING WITH A CATECHIN COMPOUND | MITSUI NORIN CO., LTD. (JP) | 1998-09-15 | — | — | US | disclosed |
| EP-0761226-A1 | Method of potentiating antibiotics with polyphenols | MITSUI NORIN CO., LTD. (JP) | 1997-03-12 | — | — | EP | disclosed |
| US-5532012-A | TEA POLYPHENOL OR THEAFLAVIN ANTIOXIDANTS BY EXTRACTION OF BLACK TEA | THOMAS J. LIPTON CO., DIVISION OF CONOPCO, INC. (US) | 1996-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595220-B2 | Cocrystals of pterostilbene and compositions comprising them | SHBG, PSEN1, SREBF1 | BCL2 960/4885KDM4E 3858/4885MAPT 68/4885 |
| US-20220031654-A1 | Standardized Bioflavonoid Composition for Regulation of Homeostasis of Host Defense Mechanism | SERPINB6, BLVRB, CFB | BCL2 502/4885KDM4E 4101/4885MAPT 4788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.